Literature DB >> 32738651

MicroRNA-responsive release of Cas9/sgRNA from DNA nanoflower for cytosolic protein delivery and enhanced genome editing.

Jinjin Shi1, Xue Yang1, Yanan Li1, Danyu Wang1, Wei Liu1, Zhenzhong Zhang1, Junjie Liu2, Kaixiang Zhang3.   

Abstract

Nanoparticle-based CRISPR/Cas9 delivery systems hold great promise for specific and precise treatment of genetic disorder diseases. Herein, we developed a DNA nanoflower-based platform for microRNA-responsive cytosolic delivery of Cas9/sgRNA complex into tumor cells. The biocompatible DNA nano-vehicles can efficiently load Cas9/sgRNA by sequence hybridization. Importantly, this hybridization can be replaced by a tumor specific miRNA through toehold-mediated strand displacement process and achieve cell-type-specific release of Cas9/sgRNA from the DNA nanoflowers. We have verified that this miRNA-responsive releasing process can significantly improve the genome editing efficiency comparing with non-responsive control. This strategy suggests a versatile way for designing more specific and efficient CRISPR-based genome therapy system by incorporating stimuli-responsive Cas9/sgRNA release process.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  CRISPR/Cas9; DNA nanoflower; cytosolic delivery; genome editing; miRNA-responsive

Mesh:

Substances:

Year:  2020        PMID: 32738651     DOI: 10.1016/j.biomaterials.2020.120221

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  6 in total

1.  Preparation of a miR-155-activating nucleic acid nanoflower to study the molecular mechanism of miR-155 in inflammation.

Authors:  Wenxin Wang; Jie Geng; Xiaohan Wu; Jianguang Zhang; Chenna Zheng; Huachun Rao; Tianyu Li; Yong Diao; Huiyong Yang
Journal:  Mol Med       Date:  2022-06-17       Impact factor: 6.376

Review 2.  Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing.

Authors:  Li Duan; Kan Ouyang; Xiao Xu; Limei Xu; Caining Wen; Xiaoying Zhou; Zhuan Qin; Zhiyi Xu; Wei Sun; Yujie Liang
Journal:  Front Genet       Date:  2021-05-12       Impact factor: 4.599

Review 3.  Nanoparticles in Clinical Translation for Cancer Therapy.

Authors:  Deepa Mundekkad; William C Cho
Journal:  Int J Mol Sci       Date:  2022-02-01       Impact factor: 5.923

Review 4.  Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing.

Authors:  Tianxu Fang; Xiaona Cao; Mysha Ibnat; Guojun Chen
Journal:  J Nanobiotechnology       Date:  2022-08-02       Impact factor: 9.429

Review 5.  Application Perspectives of Nanomedicine in Cancer Treatment.

Authors:  Shanshan Hou; Muhammad Hasnat; Ziwei Chen; Yinong Liu; Mirza Muhammad Faran Ashraf Baig; Fuhe Liu; Zelong Chen
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

Review 6.  Multivalent Aptamer Approach: Designs, Strategies, and Applications.

Authors:  Zhong Wang; Xiuying Yang; Nicholas Zhou Lee; Xudong Cao
Journal:  Micromachines (Basel)       Date:  2022-03-12       Impact factor: 2.891

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.